Pooling research results: benefits and limitations of meta-analysis (Q33730688)

29 July 2017

1 reference

title

Pooling research results: benefits and limitations of meta-analysis (English)

1 reference

29 July 2017

1 reference

J P Ioannidis

1

1 reference

PubMed ID

10481815

29 July 2017

J Lau

series ordinal

2

1 reference

29 July 2017

1 September 1999

1 reference

The Joint Commission journal on quality improvement

29 July 2017

1 reference

29 July 2017

25

1 reference

29 July 2017

9

1 reference

29 July 2017

462-469

1 reference

Meta-analysis: reconciling the results of independent studies.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Assessing possible hazards of reducing serum cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Cholesterol lowering and mortality: the importance of considering initial level of risk

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

The medical review article: state of the science

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Evaluation of guidelines for initiation of highly active antiretroviral therapy in a longitudinal cohort of HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Caution: should we be treating HIV infection early?

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Meta-analyses of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Summing up evidence: one answer is not always enough.

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

The statistical basis of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Quantitative synthesis in systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Cumulative meta-analysis of therapeutic trials for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Meta-analysis: science or religion?

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary Pneumocystis carinii prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

The promise and problems of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

The impact of high-risk patients on the results of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Publication bias in clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Randomised trials in German-language journals

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Do certain countries produce only positive results? A systematic review of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Publication bias: the case for an international registry of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Can quality of clinical trials and meta-analyses be quantified?

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Invited commentary: ecologic studies--biases, misconceptions, and counterexamples

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Uncontrolled pearls, controlled evidence, meta-analysis and the individual patient.

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Large trials vs meta-analysis of smaller trials: how do their results compare?

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Predictive ability of meta-analyses of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Discrepancies between meta-analyses and subsequent large randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

Issues in comparisons between meta-analyses and large trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930460-6

7 January 2021

10.1016/S1070-3241(16)30460-6

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10481815